Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Preventive Surgery Cost-Effective in Lynch Syndrome

By HospiMedica staff writers
Posted on 03 Apr 2007
Prophylactic surgery is both cost-effective and the best treatment for women at risk of endometrial and ovarian cancer due to Lynch syndrome, according to a new study.

Researchers at the University of California at San Francisco (UCSF; USA) developed a mathematic cost model that showed that risk-reducing surgery--hysterectomy with bilateral salpingo-oophorectomy--was more cost-effective than annual screening or routine annual check-ups. More...
The researchers used the Surveillance, Epidemiology and End Results (SEER) database from 1988 to 2001 to estimate mortality and data from UCSF to estimate the costs of care.

The cost model included such factors as screening charges, hospital stays, chemotherapy and radiation, surgery, home health care, and several other factors. Results showed that the cumulative cost of endometrial cancer would be about US$113,000 if the patients died five years after diagnosis, $194,000 if she died 10 years after diagnosis. Even if treatment was successful and the woman was cured, the cost would be about $146,000.
In contrast, the researchers estimated the cost of preventive surgery to be about $11,000.

The researchers expressed their cost-effectiveness findings using discounted life-years, which are a statistical method of standardizing patients' perception of the value of an intervention in terms of life expectancy. On that basis, preventive surgery has a cost per discounted life-year of $954, compared with $2,406 for annual screening and $3,319 for annual check-ups. The study was presented at the Society of Gynecologic Oncologists annual meeting, held in San Diego (CA, USA) during March 2007.

"Over a lifetime, annual screening was about 2.5 times as expensive as preventive surgery at age 30, and routine check-ups were about 3.5 times as expensive,” said lead author Lee-May Chen, M.D. "A combination of colectomy, hysterectomy, and bilateral salpingo-oophorectomy would provide a lot of peace of mind. If you've eliminated [the risk of] colon cancer, endometrial cancer, and ovarian cancer, you've eliminated the top three.”

Lynch syndrome--also known as hereditary non-polyposis colorectal cancer--affects one woman in 2,000. Women with the syndrome have a lifetime risk of endometrial cancer that is in the range of 40-60%, compared with 2% in the general population. At the same time, their risk of ovarian cancer ranges from 5%-12%, compared with between 1% and 2% in the general population.


Related Links:
University of California at San Francisco

Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Fetal Monitor
BT-380
New
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.